Clinical Trial

A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma

Study acronym: SPS-C
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
A single patient study to determine whether GCAR1 is safe and effective for refractory, progressive metastatic alveolar soft part sarcoma (ASPS).
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-05
notable Primary completion pushed: 2026-11-30 -> 2027-01-19 2026-08-05
minor Completion pushed: 2026-11-30 -> 2027-01-19 2026-08-05
Trial Details
NCT Number NCT07104682
Lead Sponsor University of Calgary
Conditions Alveolar Soft Part Sarcoma (ASPS), Sarcoma
Enrollment 1 participants
Start Date 2025-08-21
Primary Completion 2027-01-19 (estimated)
Study Completion 2027-01-19 (estimated)
Updated on ClinicalTrials.gov 2026-08-04